Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 03 Sept 2026 for Biomarin Pharmaceutical INC, €1.0M. Read the official filing
Filing timeline
BuySaleGeorge Eric Davis
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
George Eric Davis: trading record in brief
All filings by George Eric Davis on record concern Biomarin Pharmaceutical Inc, in the capacity of chief executive. In total, 26 filings cover trades dated from 30 April 2021 to 2 September 2026.
The open-market record consists of 8 sales worth €6.9M, with no purchase. Other entries cover 15 share grants and 3 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 3 September 2026: an open-market sale of €1.0M, in Biomarin Pharmaceutical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to George Eric Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
17,557 shares@ US$66.2840.0093% mcap9.1% of flowCommon StockSEC:0001628280-26-060572:0
1,273 shares@ US$56.050.6% of flowCommon StockSEC:0001628280-26-019862:0
7,177 shares@ US$58.513.7% of flowCommon StockSEC:0001628280-26-019010:0
6,177 shares0Common StockSEC:0001628280-26-012533:0
16,249 shares@ US$69.4410.4% of flowCommon StockSEC:0001048477-25-000037:0
11,040 shares0Common StockSEC:0001048477-25-000015:0
40,850 shares@ US$63.1023.8% of flowCommon StockSEC:0001048477-24-000112:0
301 shares@ US$68.6460.2% of flowCommon StockSEC:0001048477-24-000075:0
24,602 shares@ US$88.3420.1% of flowCommon StockSEC:0001048477-24-000054:0
10,260 shares0Common StockSEC:0001048477-24-000048:0
20,840 shares0Common StockSEC:0001048477-24-000026:0
13,764 shares@ US$95.3012.2% of flowCommon StockSEC:0001048477-23-000059:0
11,000 shares@ US$89.42389.0% of flowCommon StockSEC:0001048477-23-000033:0
317 shares@ US$66.880.2% of flowCommon StockSEC:0001209191-23-030719:0
8,900 shares0Common StockSEC:0001567619-23-005292:0
20,200 shares0Common StockSEC:0001209191-23-014614:0
1,474 shares@ US$67.810.9% of flowCommon StockSEC:0001567619-23-003998:0
3,690 shares@ US$96.343.5% of flowCommon StockSEC:0001567619-22-015635:0
7,398 shares@ US$90.006.6% of flowCommon StockSEC:0001567619-22-013886:0
341 shares@ US$62.4070.2% of flowCommon StockSEC:0001567619-22-009494:0
2,669 shares@ US$37.460.9% of flowCommon StockSEC:0001567619-22-009054:0
6,129 shares@ US$81.294.5% of flowCommon StockSEC:0001567619-22-007415:0
11,040 shares0Common StockSEC:0001567619-22-007181:0
9,370 shares0Common StockSEC:0001567619-22-006716:0
5,518 shares@ US$76.693.5% of flowCommon StockSEC:0001567619-21-014415:0
25 of 26 declarations
